Key result
Fetal echocardiography detected 0 additional cases of critical congenital heart disease in high-risk pregnancies with normal anatomic ultrasound findings, with 96.1% overall agreement (κ=0.803, P<.001).
Why the study?
The study evaluated the concordance between second-trimester anatomic ultrasound and fetal echocardiography in detecting minor and critical congenital heart disease in pregnancies meeting American Heart Association criteria.
Does fetal echocardiography improve the detection of critical congenital heart disease compared to anatomic ultrasound in high-risk pregnancies?
Cohort (n=722)
No
Does fetal echocardiography improve the detection of critical congenital heart disease compared to anatomic ultrasound in high-risk pregnancies?
In high-risk pregnancies with normal detailed anatomic ultrasound findings, routine fetal echocardiography provides limited additional benefit in detecting critical congenital heart defects.
Concordance data should not yet alter fetal echocardiography referrals; leaves open need for prospective validation in AHA-indicated pregnancies.
OBJECTIVES: To evaluate the concordance between second-trimester anatomic ultrasound and fetal echocardiography in detecting minor and critical congenital heart disease in pregnancies meeting American Heart Association criteria. METHODS: We conducted a retrospective cohort study of pregnancies in which a second-trimester fetal anatomic ultrasound examination (18-26 weeks) and fetal echocardiography were performed between 2012 and 2018 at our institution based on American Heart Association recommendations. Anatomic ultrasound studies were interpreted by maternal-fetal medicine specialists and fetal echocardiographic studies by pediatric cardiologists. Our primary outcome was the proportion of critical congenital heart disease (CCHD) cases not detected by anatomic ultrasound but detected by fetal echocardiography. The secondary outcome was the proportion of total congenital heart disease cases missed by anatomic ultrasound but detected by fetal echocardiography. Neonatal medical records were reviewed for all pregnancies when obtained and available. RESULTS: Overall, 722 studies met inclusion criteria. Anatomic ultrasound and fetal echocardiography were in agreement in detecting cardiac abnormalities in 681(96.1%) studies (κ = 0.803; P < .001). The most common diagnosis not identified by anatomic ultrasound was a ventricular septal defect, accounting for 9 of 12 (75%) missed congenital heart defects. Of 664 studies with normal cardiac findings on the anatomic ultrasound examinations, no additional instances of CCHD were detected by fetal echocardiography. No unanticipated instances of CCHD were diagnosed postnatally. CONCLUSIONS: With current American Heart Association screening guidelines, automatic fetal echocardiography in the setting of normal detailed anatomic ultrasound findings provided limited benefit in detecting congenital heart defects that would warrant immediate postnatal interventions. More selective use of automatic fetal echocardiography in at-risk pregnancies should be explored.
No takes yet. Share an insight, caveat, or question.
Krishnan et al. (2020) conducted a cohort in High-risk pregnancies (n=722). Fetal echocardiography vs. Anatomic ultrasound was evaluated on Proportion of critical congenital heart disease (CCHD) cases not detected by anatomic ultrasound but detected by fetal echocardiography. Fetal echocardiography detected 0 additional cases of critical congenital heart disease in high-risk pregnancies with normal anatomic ultrasound findings, with 96.1% overall agreement (κ=0.803, P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: